- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02047695
Women With Migraine With Aura Neuroimaging Study (WOMAN)
April 3, 2017 updated by: David Gaist, Odense University Hospital
Women With Migraine With Aura Neuroimaging (WOMAN) Study: A Population-based Study of Danish Twins
The purpose of this study is to investigate whether a particular form of migraine, migraine with aura, is associated with structural changes in the brain
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
345
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Selected from a population-based twin registry
Description
Inclusion Criteria:
- female
- case (migraine with aura), co-twin to case, or control (migraine-free)
- residency in Denmark
- no severe neurological (vascular, neurodegenerative or neuroinflammatory) disorders, or other somatic or psychiatric disorders
Exclusion Criteria:
- male
- residency outside Denmark
- registered in Civil Registry as not to be contacted by researchers
- severe neurological (vascular, neurodegenerative or neuroinflammatory) disorders, or other somatic or psychiatric disorders
- mobile metal parts or other contraindication for MRI
- weight of 130+ kilograms
- pregnancy
- subjects that wished not to be informed about abnormal findings on MRI
- chronic tension-type headache, medication overuse headache, or cluster headache (diagnosed through physician interview)
- frequent tension-type headache (control group only, self-reported or diagnosed through physician interview)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Migraine with aura
Participants with migraine with aura (cases), their co-twins, and unrelated migraine-free twins (controls)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evidence of white matter hyperintensities or subclinical ischaemic stroke confirmed by MRI
Time Frame: At time of MRI
|
At time of MRI
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evidence of other structural and functional changes in brain
Time Frame: At time of MRI
|
At time of MRI
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David Gaist, MD, PhD, Department of Neurology, Odense University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
January 26, 2014
First Submitted That Met QC Criteria
January 26, 2014
First Posted (Estimate)
January 28, 2014
Study Record Updates
Last Update Posted (Actual)
April 4, 2017
Last Update Submitted That Met QC Criteria
April 3, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-20100126
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine With Aura
-
Brigham and Women's HospitalNot yet recruitingMigraine Disorders | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Hinge Health, IncRecruitingMigraine | Migraine Without Aura | Migraine With AuraUnited States
-
TheranicaCompletedMigraine Without Aura | Migraine With AuraIsrael
-
California Medical Clinic for HeadacheUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraUnited States
-
Hospital Clínico Universitario de ValladolidUniversity of Valladolid; Complejo Asistencial Universitario de Palencia; Complejo...RecruitingBrain Diseases | Migraine Disorders | Migraine Without Aura | Migraine With AuraSpain
-
Wake Forest University Health SciencesNational Center for Advancing Translational Sciences (NCATS); W.G. Bill Hefner...WithdrawnMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura
-
University Hospital, AkershusNorwegian Foundation for Health and Rehabilitation; Norwegian Chiropractic...CompletedMigraine Without Aura | Migraine With AuraNorway
-
Danish Headache CenterRecruitingMigraine With Aura | Migraine AuraDenmark
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedMigraine Without Aura | Migraine With AuraSpain, France, Italy, Netherlands, Turkey, Belgium, Hungary, Czechia, Denmark, Germany, Greece, Norway, Portugal, Sweden
-
Vastra Gotaland RegionNot yet recruiting